소변 검사 컵 시장 규모, 점유율, 동향 분석 : 멸균도별, 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Urine Testing Cups Market Summary

The global urine testing cups market size was estimated at USD 1.33 billion in 2024 and is projected to reach USD 1.96 billion by 2030, growing at a CAGR of 6.69% from 2025 to 2030. The demand for urine testing cups products is rising owing to the increasing prevalence of drug abuse, expanding use of urine testing in disease detection and chronic condition monitoring, technological advancements, and rising demand for point-of-care and home-based diagnostic tools.

The surge in drug-related violations, as reported by the Drugs Control Administration (DCA) in Hyderabad, with 573 breaches in 2024 compared to just 56 in 2023, indicates a sharp rise in the circulation and abuse of illegal and spurious substances. This includes the seizure of narcotics worth over USD 1.3 million and the arrest of individuals, including medical professionals, involved in distributing psychoactive substances. These developments underscore the growing need for efficient, on-the-spot drug detection tools across healthcare, law enforcement, and workplace environments. As a result, the demand for urine testing cups, owing to their portability, rapid results, and ability to detect a wide range of illicit substances, is poised to rise significantly.

The significant global rise in drug use has majorly contributed to the growth of the market. For instance, according to the news published in June 2024 the World Drug Report 2024 reveals that the number of people who use drugs rose to 292 million in 2022, marking a 20% increase over the past decade, as shown in the graph below. This surge, driven by the widespread use of substances like synthetic opioids and cannabis, highlights the growing need for effective drug monitoring tools. Moreover, with an estimated 7 million individuals coming into formal contact with law enforcement for drug-related offences in 2022, there is a pressing demand for quick and reliable testing methods. The upward trend shown in the graph further supports this, emphasizing the critical role of urine testing cups in both healthcare and criminal justice settings to facilitate early detection, treatment, and prevention efforts.

According to data updated by the American Kidney Fund in February 2025, an estimated 35.5 million Americans are living with kidney disease, with nearly 555,000 undergoing dialysis and about 815,000 facing kidney failure. This sharp rise in chronic kidney conditions highlights the expanding use of urine testing in disease detection and long-term health monitoring. Urine testing cups offer a simple, non-invasive, and cost-effective method to detect early signs of kidney dysfunction, enabling timely medical intervention. As kidney disease now affects over 14% of American adults, disproportionately impacting people of color, the demand for regular screening tools like urine testing cups is increasing, making them vital in managing chronic health conditions and supporting preventive healthcare efforts.

Global Urine Testing Cup Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global urine testing cups market report on the basis of sterility, product, application, end-use, and region:

• Sterility Outlook (Revenue, USD Million, 2018 - 2030)
• Sterile
• Non- Sterile
• Product Outlook (Revenue, USD Million, 2018 - 2030)
• With Temperature Strip
• Without Temperature Strip
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Drug Testing
• Pregnancy Testing
• Disease Detection
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Use
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Urine Testing Cups Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Urine Testing Cups Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Urine Testing Cups Market: Sterility Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Urine Testing Cups Market Movement Analysis
• 4.3. Global Urine Testing Cups Market Size & Trend Analysis, by Sterility, 2018 to 2030 (USD Million)
• 4.4. Sterile
  • 4.4.1. Sterile market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Non- Sterile
  • 4.5.1. Non- Sterile market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Urine Testing Cups Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Urine Testing Cups Market Movement Analysis
• 5.3. Global Urine Testing Cups Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. With Temperature Strip
  • 5.4.1. With temperature strip market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Without Temperature Strip
  • 5.5.1. Without temperature strip market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Urine Testing Cups Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Urine Testing Cups Market Movement Analysis
• 6.3. Global Urine Testing Cups Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Drug Testing
  • 6.4.1. Drug testing market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Pregnancy Testing
  • 6.5.1. Pregnancy testing market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Disease Detection
  • 6.6.1. Disease detection market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Urine Testing Cups Devices: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Urine Testing Cups Market Movement Analysis
• 7.3. Global Urine Testing Cups Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospitals & clinics market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Diagnostic Laboratories
  • 7.5.1. Diagnostic laboratories market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Home Use
  • 7.6.1. Home Use market estimates and forecast 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Urine Testing Cups Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. Reimbursement scenario
    • 8.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement scenario
    • 8.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 8.5.2. India
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 8.5.4. South Korea
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement scenario
    • 8.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. BD
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Abbott Toxicology
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Labcon North America
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Quest Diagnostics
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Co-Innovation Biotech Co., Ltd.
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Alfa Scientific Designs, Inc.
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Medline Industries, LP
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Globe Scientific Inc.
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. CLIAWAIVED
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. CLARITY DIAGNOSTICS
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Sarstedt Inc
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. Wondfo
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Product benchmarking
    • 9.2.12.4. Strategic initiatives
• 9.3. Heat Map Analysis/ Company Market Position Analysis
• 9.4. Estimated Company Market Share Analysis, 2024
• 9.5. List of Other Key Market Players